GlassScriptPhysician profile
Neil Ermitano
NPI 1649620634
$14,047.23
in general payments reported to CMS, 2019-2025
11 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,490 · 2020: $699 · 2022: $2,181 · 2023: $401 · 2024: $1,044 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045 · Travel and Lodging: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.45 |
| Travel and Lodging | $632.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $9,180.47 | 2019-2024 | |
| Arthrex, INC. | $1,888.00 | 2019 | |
| Stryker Corporation | $997.44 | 2020-2025 | Citrefix, Viaflow, Easyfuse |
| Organogenesis INC. | $488.98 | 2022-2025 | Puraply, Affinity, Affinity |
| Medline Industries LP | $418.80 | 2024 | |
| Wright Medical Technology, INC. | $311.93 | 2019-2020 | |
| Tactile Systems Technology INC | $262.73 | 2020-2025 | Nimbl, Flexitouch Plus |
| International Life Sciences | $257.96 | 2024 | Flexband |
| Integra Lifesciences Corporation | $145.59 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $69.88 | 2019 | |
| Kerecis Limited | $25.45 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Ermitano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.